Search Results for: DNA VACCINES MARKET DNA Vaccines


November 19, 2015

SINGLE-USE MARKET – Rise of Single-Use Technologies & Systems in Biopharmaceuticals November 19, 2015

Kevin James and Shalini S. Dewan of BCC Research believe eliminating the risk of contamination is the greatest challenge faced by manufacturers of biopharmaceuticals, and currently, this requires high-level monitoring of critical manufacturing processes. Single-use technology aids biopharmaceutical manufacturers in overcoming this challenge by reducing or eliminating the need for sterilization between batches, thereby improving operational efficiency.

April 15, 2019

Paragon Bioservices to be Acquired for $1.2 Billion April 15, 2019

Catalent, Inc. and Paragon Bioservices, Inc. and Catalent Inc. recently announced they have entered into a definitive agreement under which Catalent will acquire Paragon for $1.2 billion.

October 3, 2016

SPECIAL FEATURE – Platform Technologies: Not Just for Big Pharma October 3, 2016

Contributor Cindy H. Dubin recently spoke with several companies that are debunking the theory that access to the latest technological platforms to aid efficient drug discovery and development is limited to Big Pharma, which can more easily justify the costs of creating and operating innovative platforms.


May 2, 2018

January 2009

Monodisperse Microspheres for parenteral Drug Delivery Gert Veldhuis, PhD, and Mi­riam Gironess, PhD, MSc, review a novel manufacturing process that...
May 2, 2018

April 2009

Growth or Recession: Selling Solutions is the Answer Derrek G. Hennecke, MBA, profiles in this 6-part series, unique strategies for...